top of page

beLAB2122 strengthen innovations in the region

Germany's first BRIDGE by Evotec, Bristol Myers Squibb and five leading research institutions has made an initial selection from among numerous projects. Here, beLAB2122 shows that the combination of forces can raise the potential of academic research quickly and efficiently.

Read more in this article published in transcript 3.2022 (Biocom)

Download PDF • 24.35MB


bottom of page